— Know what they know.
Not Investment Advice
Also trades as: COP.DE (XETRA) · $vol 1M · CMPVF (OTC) · $vol 0M · CMPUY (OTC) · $vol 0M

0MSD.L LSE

CompuGroup Medical SE & Co. KGaA
1W: +inf% 1M: -0.9% 3M: +0.5% YTD: +2.4%
€41.50
Last traded 2026-06-30 — delisted
LSE · Technology · Software - Infrastructure · €1.2B mcap

Income Trends

Revenue
$1.2B -2.8% ▼
5Y CAGR: +9.1%
Gross Profit
$965M -4.0% ▼
5Y CAGR: +31.0%
Operating Income
$106M -14.0% ▼
5Y CAGR: -2.3%
Net Income
$35M -24.6% ▼
5Y CAGR: -12.1%
EPS (Diluted)
$0.66 -25.0% ▼
5Y CAGR: -13.1%
EBITDA
$207M -4.1% ▼
5Y CAGR: +3.3%

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
Revenue$837M$1.0B$1.1B$1.2B$1.2B
YoY Growth+12.3%+22.5%+10.2%+5.1%-2.8%
Cost of Revenue$124M$739M$172M$183M$189M
Gross Profit$713M$286M$958M$1.0B$965M
Gross Margin85.2%27.9%84.8%84.6%83.6%
R&D Expenses$0$124M$0$0$0
SG&A Expenses$43M$46M$45M$38M$35M
Operating Expenses$588M$763M$851M$882M$859M
Operating Income$125M$109M$107M$123M$106M
Operating Margin15.0%10.6%9.5%10.4%9.2%
Interest Expense$8M$8M$12M$24M$33M
Income Before Tax$110M$98M$107M$73M$62M
Tax Expense$37M$29M$33M$26M$27M
Net Income$73M$69M$73M$46M$35M
Net Margin8.7%6.7%6.5%3.9%3.0%
EPS (Diluted)$1.36$1.30$1.40$0.88$0.66
EBITDA$192M$214M$228M$213M$207M
Shares Outstanding54M53M52M52M53M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms